AR and prostate carcinoma: However, studies aimed at evaluating adverse clinical impacts of AR inhibitors in prostate cancer patients evidenced a number of adverse events associated with the Central Nervous System functions, such as amnesia, unspecified cognitive disorders, memory impairment and state of confusion [45].